Century Therapeutics Posts $0.11 Q3 Loss Per Share as Net Loss Narrows

Your call?🐂 Bullish🐻 Bearish

The company had $174.1 million in cash, cash equivalents and investments at quarter-end and estimated the balance would support operations into the first quarter of 2029.